A new survey by the British Menopause Society (BMS) has revealed that there is an underlying gap in the knowledge of newly qualified healthcare professionals around the transition to menopause.
The non-hormonal drug fezolinetant, marketed by Astellas under the name Veoza, alleviates vasomotor symptoms (VMS) – also known as hot flushes and night sweats – that many women suffer from during...
NICE recommends cognitive behavioural therapy (CBT) alongside or as an alternative to HRT to alleviate the effects of the menopause
The new prescription pre-payment certificate (PPC) launched on the 1st April and has allowed women to access a year’s worth of HRT for just £19.30, saving them hundreds of pounds.
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support
